First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Per-recipient award not stated for alaska native and native hawaiian serving institutions, asian american native american pacific islander serving institutions (aanapisiss), business, city or township governments, county governments, eligible agencies of the federal government, faith-based or community-based organizations, for profit organizations other than small businesses, hispanic-serving institutions, historically black colleges and universities (hbcus), independent school districts, indian/native american tribal governments (other than federally recognized), native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofit, nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, other legal entity, private institutions of higher education, public agency, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, regional organizations, small businesses, special district governments, state governments, tribal government, tribally controlled colleges and universities (tccus), u.s. territory or possession, closing Oct 15, 2027.

In one sentence

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) does not state a per-recipient award amount, open to alaska native and native hawaiian serving institutions, asian…

How much money is available?

Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.

Source wording: “Not stated on page”

Who can apply?

When does it close?

Response date listed as Oct 15, 2027

What can the money be used for?

These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.

How hard is the application?

Application effort

Not confirmed

Disbursement

Not confirmed

Matching funds

No

Cost sharing listed as false

Who has received this funding?

Common questions

Every answer below is a stored field from this record. Questions the source did not answer are not asked.

When is the application deadline?

Oct 15, 2027. Response date listed as Oct 15, 2027

Who is eligible to apply?

Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Business, City or township governments, County governments, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, For profit organizations other than small businesses, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Independent school districts, Indian/Native American Tribal Governments (Other than Federally Recognized), Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofit, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Other Legal Entity, Private institutions of higher education, Public Agency, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Regional Organizations, Small businesses, Special district governments, State governments, Tribal Government, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession.

What can the funding be used for?

First in human (FIH) and Phase II studies of novel agents with assessment of target engagement, brain exposure, pharmacological effects, safety, and tolerability, Phase II/proof of concept (PoC) studies evaluating drug impact on clinically relevant physiological systems and clinical indicators of effect, First in human and early feasibility studies (EFS) of novel neuromodulatory devices, Early stage clinical trials of novel mechanism of action investigational drugs, Novel drugs for pediatric populations with psychiatric disorders, Device or combination treatments, as classified by the source.

Is matching funding required?

No. The source states that no matching funds are required. Cost sharing listed as false